Exosome Therapeutics Market to be Dominated By Hybrid Exosome Therapy through 2028
Increasing molecular diagnosis
and the emerging role of exosomes in the treatment of chronic diseases to drive
the global exosome therapeutics market in the forecast period 2024-2028.
According to TechSci Research report, “Exosome Therapeutics
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028,” the
Exosome Therapeutics market is anticipated to grow at a significant rate in the
forecast period 2024-2028. This can be ascribed due to growing
technological breakthroughs in exosome isolation and analysis for the treatment
of chronic diseases such as cardiovascular diseases, and cancer across the
region. Also, the growing demand for exosomes as a biomarker in research
institutes is expected to enhance the demand for exosome therapeutics during
the forecast period. Additionally, growing advancements in the development of
genotype and phenotype-specific drug assays by pharmaceutical manufacturers
have further demanded the exosome therapeutics market over the years.
Similarly, the rising demand for differential tests for the diagnosis and
screening of chronic diseases and the high therapeutic potential of exosomes in
cancer diagnostics is a major factor in the enhancement of the exosome
therapeutics market in the forecast period.
However,
the high initial investment for the development of better healthcare infrastructure
may restrain the global exosome therapeutics market growth in the forecast
period. Also, the lack of diagnostic centers in the developing region may
hamper the growth of the market during the forecast period. Also lack of
skilled professionals for handling the instruments in the research lab as well
as diagnostic labs may hamper the growth of the global exosome therapeutics
market in the forecast period.
Browse over XX market data Figures
spread through XX
Pages and an in-depth TOC on "Exosome Therapeutics Market"
The
global exosome therapeutics market is segmented into exosome type, source, therapy,
application, end user, region, and competitive landscape.
Based
on Therapy, the exosome therapeutics market can be segmented into
Immunotherapy, Chemotherapy, Gene Therapy. The immunotherapy segment is
expected to drive the growth of the market. This can be ascribed due to the
growing adoption of new therapies for the treatment of chronic diseases. Also,
the growing prevalence of different types of cancers such as melanoma, skin
cancer, and stomach cancer among the aging population are demanding better
treatment so government organizations are investing for new therapies and
techniques which will further boost the growth of the market during the
forecasted period.
Based on application, the market can be segmented
into Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, and Others. The
diagnostic segment is expected to propel the growth of the market. This can be
ascribed due to the rise in the incidence of chronic diseases and the growing
demand for early diagnosis, increasing the number of the diagnostic sector across
the globe. In addition, one of the key
aspects driving this market's demand upward is the growing need for more
development and research activities, which is further encouraged by global exosome
therapeutics market during the forecasted period.
Major companies are operating in
global exosome therapeutics market:
- Aethlon Medical, Inc.-Exosome Sciences
- Aegle Therapeutics
- Anjarium Biosciences AG
- Exogenus Therapeutics SA
- Lonza Group
- Capricor Therapeutics, Inc.
- Avalon Globocare Corp
- Stem Cell Medicine Ltd.
- Evox Therapeutics Limited
- EV Therapeutics
In Feb 2022,
Thermo Fisher Scientific signed an agreement with Bio-Techne Corporation which
is a company that develops, manufactures, and sells life science reagents,
instruments, and services. Under the agreement, Bio-Techne aimed to exclusively
finish the design of and commercialize the ExoTRU kidney transplant rejection
test developed by Exosome Diagnostics, a Bio-Techne brand. ExoTRU is a
non-invasive multigene urine-based liquid biopsy test that offers crucial allograft
health information to help clinician decision-making in handling kidney
transplant patients and optimizing patient care.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“The North America region dominates the global exosome
therapeutics market and is expected to maintain its dominance in the coming
years due to the growing prevalence of chronic disorders such as cancer,
diabetes, and autoimmune disorders across the region. Similarly, a growing
number of product launches for exosome therapeutics is a major factor driving
the growth of the market. Also, increasing the number of major key players
along with the growing development of research activities in the pharmaceuticals
and biopharmaceutical sector across the region is also propelling the growth of
the market during the forecast period. Additionally, growing healthcare
expenditure in the developing region and rise in the number of exosome
diagnostic and therapeutic industries along with growing demand for molecular
diagnosis is anticipated to boost the growth of the market over the years.
However, the growth potential in the emerging economies for exosome
therapeutics and the growing use of anti-aging therapy is expected to drive the
growth of the exosome therapeutics market till 2028’ said
Mr. Karan Chechi, Research Director with TechSci Research, a research based
global management consulting firm.
“Exosome
therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
2018-2028 Segmented By Exosome Type (Natural v/s Hybrid), By
Source (Mesenchymal Stem Cells, Blood,
Body Fluids, Others), By Therapy (Immunotherapy, Chemotherapy, Gene Therapy),
By Application (Metabolic Disorders, Oncology,
Cardiac Disorders, Neurology, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others),
By Region,” has
evaluated the future growth potential of global exosome therapeutics market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision-makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global exosome therapeutics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com